Friday, September 30, 2022

International Conference on Infectious Diseases


 

Acinetobacter in Healthcare Settings| International Conference on Infectious Diseases| Summit Your Abstract 

Visit: https://infectious-diseases-conferences.pencis.com/
Online Nomination: https://x-i.me/ian1
Abstract Submission Link: https://x-i.me/rajeinfe

#infection #infectiousdiseases #bacteria #bacteriology #virus #conferences #research #immunology #virology #coronavirus #covid-19 #awards


Acinetobacter in Healthcare Settings

Acinetobacter is a group of bacteria (germs) commonly found in the environment, like in soil and water. While there are many types, the most common cause of infections is Acinetobacter baumannii, which accounts for most Acinetobacter infections in humans.

Acinetobacter baumannii can cause infections in the blood, urinary tract, and lungs (pneumonia), or in wounds in other parts of the body. It can also “colonize” or live in a patient without causing infections or symptoms, especially in respiratory secretions (sputum) or open wounds.

These bacteria are constantly finding new ways to avoid the effects of the antibiotics used to treat the infections they cause. Antibiotic resistance occurs when the germs no longer respond to the antibiotics designed to kill them. If they develop resistance to the group of antibiotics called carbapenems, they become carbapenem-resistant. When resistant to multiple antibiotics, they’re multidrug-resistant. Carbapenem-resistant Acinetobacter are usually multidrug-resistant.

How common are these infections?

In 2017, carbapenem-resistant Acinetobacter caused an estimated 8,500 infections in hospitalized patients and 700 estimated deaths in the United States [Source: 2019 AR Threats Report].

Who is at risk?

Acinetobacter infections typically occur in people in healthcare settings. People most at risk include patients in hospitals, especially those who:

  • are on breathing machines (ventilators)
  • have devices such as catheters
  • have open wounds from surgery
  • are in intensive care units
  • have prolonged hospital stays

In the United States, Acinetobacter infections rarely occur outside of healthcare settings. However, people who have weakened immune systems, chronic lung disease, or diabetes may be more susceptible

How is it spread?

Acinetobacter can live for long periods of time on environmental surfaces and shared equipment if they are not properly cleaned. The germs can spread from one person to another through contact with these contaminated surfaces or equipment or though person to person spread, often via contaminated hands.

How can you avoid getting an infection?

Patients and caregivers should:

  • keep their hands clean to avoid getting sick and spreading germs that can cause infections
    • wash their hands with soap and water or use alcohol-based hand sanitizer, particularly before and after caring for wounds or touching a medical device
  • remind healthcare providers and caregivers to clean their hands before touching the patient or handling medical devices
  • allow healthcare staff to clean their room daily when in a healthcare setting

In addition to hand hygiene, healthcare providers should pay careful attention to recommended infection control practices, including rigorous environmental cleaning (e.g., cleaning of patient rooms and shared equipment), to reduce the risk of spreading these germs to patient.

How are these infections treated?

Acinetobacter infections are generally treated with antibiotics. To identify the best antibiotic to treat a specific infection, healthcare providers will send a specimen (often called a culture) to the laboratory and test any bacteria that grow against a set of antibiotics to determine which are active against the germ. The provider will then select an antibiotic based on the activity of the antibiotic and other factors, like potential side effects or interactions with other drugs.

Unfortunately, many Acinetobacter germs are resistant to many antibiotics, including carbapenems, which makes them difficult to treat with available antibiotics.

What is CDC doing to address Acinetobacter infections?

CDC tracks the germ, and the infections it can cause, through its Emerging Infections Program. Additionally, CDC works closely with partners, including public health departments, other federal agencies, healthcare providers, and patients, to prevent healthcare infections and to slow the spread of resistant germs.



Monday, September 26, 2022

International Conference on Infectious Diseases

News: Avian influenza or bird flu refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses.

Visit: https://infectious-diseases-conferences.pencis.com/
Online Nomination: https://x-i.me/ian1
Abstract Submission: https://x-i.me/rajeinfe

Avian influenza refers to disease in birds caused by infection with avian (bird) influenza (flu) Type A viruses. Avian influenza A viruses have been isolated from more than 100 different species of wild birds around the world. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Wild aquatic birds include waterbirds (waterfowl) such as ducks, geese, swans, gulls, and terns, and shorebirds, such as storks, plovers, and sandpipers. Wild aquatic birds, especially dabbling ducks, are considered reservoirs (hosts) for avian influenza A viruses. Wild aquatic birds can be infected with avian influenza A viruses in their intestines and respiratory tract, but some species, such as ducks, may not get sick. However, avian influenza A viruses are very contagious among birds, and some of these viruses can sicken and even kill certain domesticated bird species, including chickens, ducks and turkeys.

Infected birds can shed avian influenza A viruses in their saliva, nasal secretions, and feces. Susceptible birds become infected when they have contact with the virus as it is shed by infected birds. They also can become infected through contact with surfaces that are contaminated with virus from infected birds.

Friday, September 23, 2022

International Research Awards on Infectious Diseases


International Research Awards on Infectious Diseases| Upcoming Event| Nominate Your Profile

visit: https://infectious-diseases-conferences.pencis.com/

Monday, September 19, 2022

International Conference on Infectious Diseases

News: I've had COVID and am constantly getting colds. Did COVID harm my immune system? Am I now at risk of other infectious diseases?

visit: https://infectious-diseases-conferences.pencis.com/

Online Nomination: https://x-i.me/ian1

So you've had COVID and have now recovered. You don't have ongoing symptoms and luckily, you don't seem to have developed long COVID.

But what impacts has COVID had on your overall immune system?

It's early days yet. But growing evidence suggests there are changes to your immune system that may put you at risk of other infectious diseases.

Monday, September 12, 2022

International Conference on Infectious Diseases


News: Mānuka Honey Could Treat Potentially Lethal, Drug Resistant Lung Infections

Humans have used honey for its antimicrobial properties for millennia, and science has only recently been catching up.

visit: https://infectious-diseases-conferences.pencis.com/
Online Nomination: https://x-i.me/ian1

#infectiousdiseases #infection #bacteria #virology #conferences #pathology #malaria #illness #awards

Saturday, September 3, 2022

International Conference on Infectious Diseases


News: Amid spurt in viral infections, BMC asks all hospitals to send samples for RT-PCR, genome sequencing tests.

visit: https://infectious-diseases-conferences.pencis.com/

#infection #virology #skininfection #infectiousdisease #conference #bacteriology #virus #microbiology #pathology